The specific use of Teresa varies from person to person, you should consult a professional doctor, and the specific dosage is based on the condition.
Teresa, also known as ositinib mesylate, is a third-generation targeted drug against EGFR gene mutation in non-small cell lung cancer, applicable to advanced non-small cell lung cancer. The survival period after taking the drug is usually more than three years or so, and the specific effect varies from person to person. There are still some patients with drug resistance during the period of taking the drug.
During the application of OXITINI mesylate, avoid eating foods containing furanocoumarin, because furanocoumarin will inhibit the activity of the enzyme that breaks down the drug in the human body, so that the amount of Teresa in the bloodstream will increase exponentially, and aggravate the side effects of the drug. Also avoid taking this drug with strong tea to avoid precipitation, which will affect drug absorption.
It is recommended that patients with indications for Ocitinib Mesylate consult their doctor first, and not use the drug blindly to avoid drug resistance. Consult your doctor in case of any discomfort.